Life Sciences Biz Paying Up To $200M For CBD Drugmaker
Hogan Lovells-led Harmony Biosciences said on Monday it would pay up to $200 million to acquire fellow pharmaceutical company and CBD-focused drugmaker Zynerba, advised by Goodwin Procter....To view the full article, register now.
Already a subscriber? Click here to view full article